24.08.2013 Views

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Complex traits and polygenic disorders<br />

to three SNPs in strong linkage disequilibrium with the deletion was<br />

observed. This is the first risk factor predisposing only to skin-type <strong>of</strong><br />

psoriasis supporting the concept <strong>of</strong> partially overlapping, but different<br />

etiological factors underlying skin and joint manifestations.<br />

P09.101<br />

High-resolution association mapping in the mHc region<br />

identifies multiple independent loci for psoriatic arthritis<br />

P. Rahman1 , N. Roslin2 , F. Pellett3 , A. Paterson2 , J. Beyene4 , M. Lemire5 , L.<br />

Peddle1 , A. Pope1 , C. Greenwood3 , D. Gladman3 ;<br />

1 2 Memorial University <strong>of</strong> Newfoundland, St. John’s, NL, Canada, Program in<br />

<strong>Genetics</strong> and Genome Biology, The Hospital for Sick Children Research Institute,<br />

Toronto, ON, Canada, 3Toronto Western Hospital, University <strong>of</strong> Toronto,<br />

Toronto, ON, Canada, 4Child Health and Evaluative Science, The Hospital for<br />

Sick Children Research Institute, Toronto, ON, Canada, 5Informatics and Biocomputing,<br />

Ontario Institute for Cancer Research, Toronto, ON, Canada.<br />

Objectives: To identify SNPs in the MHC region which are associated<br />

with PsA using a high density map.<br />

Methods: 909 individuals (422 cases and 487 controls) were genotyped<br />

for 2299 SNPs in a 5 Mb region on chromosome 6 encompassing the<br />

MHC region, using Illumina’s MHC Panel Set. The patients were from<br />

two well established centers with an expertise in PsA. A stratified case/<br />

control analysis was conducted on each SNP separately to test for allelic<br />

association with PsA. A Breslow-Day test was used to determine if<br />

the odds ratio estimates differed between the two populations.<br />

Results: 17 SNPs from 13 regions were associated with PsA (p-values<br />

< 10-5 ); we report the results for these SNPs, noting their location relative<br />

to genes, and their linkage disequilibrium (LD, based on r2 ) with<br />

each other. SNPs rs2734922 (between HLA-H and HLA-A), rs1150735<br />

(between RNF39 and TRIM31), rs11965214 (KIAA1949), rs3130933<br />

(between TCF19 and POU5F1), rs879882 and rs887468 (both between<br />

POU5F1 and HGC27), rs2523619 and rs2442719 (both between<br />

HLA-C and HLA-B; the latter tags HLA-C*0802), rs6936035 (between<br />

HLA-B and MICA) and rs2516470 (between MICA and HCP5)<br />

were associated with PsA, however, none were in strong pairwise LD.<br />

In a subset <strong>of</strong> controls who have also been genotyped for HLA-Cw6,<br />

we observed that rs12191877 and rs3906272 are in LD with this allele<br />

(r2 =0.69 and 0.60, respectively).<br />

Conclusions: Multiple regions within the MHC are associated with PsA<br />

and pairwise LD information suggests that the majority <strong>of</strong> these signals<br />

are independent.<br />

P09.102<br />

TNFα promoter polymorphisms in psoriatic arthritis patients in<br />

Romania<br />

O. M. Popa 1 , C. Ci<strong>of</strong>u 2 , M. Dutescu 3 , M. Bojinca 2 , R. Sfrent-Cornateanu 1 , V.<br />

Bojinca 4 , M. Milicescu 5 , C. Bara 1 , L. Popa 6 ;<br />

1 Department <strong>of</strong> Immunology and Physiopathology, University <strong>of</strong> Medicine and<br />

Pharmacy Carol Davila, Bucharest, Romania, 2 Department <strong>of</strong> Rheumatology<br />

and Internal Medicine, University <strong>of</strong> Medicine and Pharmacy Carol Davila, Bucharest,<br />

Romania, 3 National Hematology Institute Pr<strong>of</strong>. C.T. Nicolau, Bucharest,<br />

Romania, 4 Department <strong>of</strong> Rheumatology, University <strong>of</strong> Medicine and Pharmacy<br />

Carol Davila, Bucharest, Romania, 5 University <strong>of</strong> Medicine and Pharmacy Carol<br />

Davila, Bucharest, Romania, 6 Molecular Biology Department, Grigore Antipa<br />

National Museum <strong>of</strong> Natural History, Bucharest, Romania.<br />

Background Tumour necrosis factor α (TNFα) is a proinflammatory<br />

cytokine <strong>of</strong> critical importance in psoriatic arthritis (PsA) due to his<br />

high levels in synovial membrane and fluid and by the efficiency <strong>of</strong><br />

anti-TNFα treatments in PsA patients [1, 2]. Genetic studies <strong>of</strong> TNFα<br />

polymorphisms in PsA have produced different results that may reflect<br />

differences in the ethnic background [3].<br />

Objectives The aim <strong>of</strong> this study was to investigate two TNFα most<br />

studied polymorphisms in PsA patients from Romania.<br />

Methods 45 unrelated well diagnosed patients with PsA (25/20 F/M)<br />

and 109 healthy unrelated organ donors (46/63 F/M) were typed for<br />

TNFα -308G/A (rs 1800629) and -238G/A (rs 361525) polymorphisms<br />

by TaqMan SNP Genotyping Assay C_7514879_10 and C_2215707_<br />

10 respectively (Applied Biosystems, USA).<br />

Results The observed genotypes for the TNFα-308G/A polymorphism<br />

(1AA, 6GA, 38GG in cases, respectively 4AA, 24GA, 79GG in controls)<br />

and for the TNFα-238G/A polymorphism (0AA, 5GA, 40GG in cases,<br />

respectively 0AA, 5GA, 102GG in controls) showed no departure from<br />

Hardy-Weinberg equilibrium (HWE). The same results were obtained<br />

when only B27 negative cases and controls were analyzed.<br />

Conclusion The present study shows no departure from HWE in PsA<br />

patients in Romania, and no potential association <strong>of</strong> any investigated<br />

allele with the susceptibility to this disease, although a larger number<br />

<strong>of</strong> patients may be required to verify this conclusion.<br />

References:<br />

1.Goupille P., Joint Bone Spine 2005;72:466-470<br />

2.Seitz M et al., Rheumatology 2007; 46:93-96<br />

3.Rahman P et al., Ann. Rheum. Dis. 2006; 65:919-923<br />

P09.103<br />

Autoimmune-associated LYP-W620 variant reduces t cell<br />

activation by altering a recirpocal feedback mechanism<br />

E. Fiorillo 1,2 , V. Orrù 1,3 , Y. Liu 1 , S. Stanford 1 , M. Salek 4 , N. Rapini 5 , L. Delogu 1 ,<br />

P. Saccucci 5 , F. Angelini 5 , M. Manca Bitti 5 , M. C. Rosatelli 6 , O. Acuto 7 , N. Bottini<br />

1 ;<br />

1 Institute for Genetic Medicine, Los Angeles, CA, United States, 2 Dept. <strong>of</strong> Biomedical<br />

Science and Biotechnology, University <strong>of</strong> Cagliari, Cagliari, Italy, 3 Dept.<br />

<strong>of</strong> Biomedical Science, University <strong>of</strong> Sassari, Sassari, Italy, 4 Sir William Dunn<br />

School <strong>of</strong> Pathology, Oxford University, Oxford, United Kingdom, 5 Dept. <strong>of</strong> Biopathology,<br />

Division <strong>of</strong> Pediatrics, University <strong>of</strong> Rome “Tor Vergata”, Rome, Italy,<br />

6 Dipartimento di Scienze Biomediche e Biotecnologie, Università degli Studi<br />

di Cagliari, Cagliari, Italy, 7 Sir William Dunn School <strong>of</strong> Pathology, Università di<br />

Oxford, Oxford, United Kingdom.<br />

A missense C1858T single nucleotide polymorphism (SNP) in the<br />

PTPN22 gene recently emerged as a major risk factor for human autoimmunity.<br />

PTPN22 encodes the lymphoid tyrosine phosphatase LYP,<br />

which forms a complex with the kinase Csk and is a critical negative<br />

regulator <strong>of</strong> signaling through the T cell receptor (TCR). The C1858T<br />

SNP results in the LYP-R620W variation within the LYP-Csk interaction<br />

motif. LYP-W620 exhibits a greatly reduced interaction with Csk and<br />

is a gain-<strong>of</strong>-function inhibitor <strong>of</strong> signaling. Here we show that LYP constitutively<br />

interacts with its substrate Lck in a Csk-dependent manner.<br />

TCR-induced phosphorylation <strong>of</strong> LYP by Lck on an inhibitory tyrosine<br />

residue releases tonic inhibition <strong>of</strong> signaling by LYP. The R620W variation<br />

disrupts the interaction between Lck and LYP, leading to reduced<br />

phosphorylation <strong>of</strong> LYP and ultimately to gain-<strong>of</strong>-function inhibition <strong>of</strong><br />

T cell signaling.<br />

P09.104<br />

PTPN gene polymorphism in autoimmune endocrine diseases<br />

M. Fichna1 , M. Żurawek1 , J. Nowak1 , P. Fichna2 , D. Januszkiewicz1,2 ;<br />

1 2 Institute <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong>, Poznan, Poland, University <strong>of</strong> Medical Sciences,<br />

Poznan, Poland.<br />

Autoimmune destruction <strong>of</strong> glandular cells is the main reason <strong>of</strong> type<br />

1 diabetes (T1DM) and Addison’s disease (AAD). Both diseases present<br />

complex genetic background, with prominent role <strong>of</strong> predisposing<br />

polymorphisms in genes involved in immune reaction. Intriguing candidate<br />

is PTPN22 gene, which encodes lymphoid tyrosine phosphatase<br />

LYP. Aim <strong>of</strong> study was to analyse associations <strong>of</strong> PTPN22 G(-1123)C<br />

and C1858T polymorphisms with susceptibility to T1DM and AAD in<br />

Polish population. Study comprised 215 T1DM patients (120 females<br />

and 95 males) and 87 with AAD (65 females and 22 males), compared<br />

to 236 control subjects (133 females and 103 males). Mean age <strong>of</strong><br />

disease onset was 8.3 (±4.3) years for T1DM and 35.2 (±11.5) years<br />

for AAD. No difference was found in distribution <strong>of</strong> G(-1123)C polymorphism<br />

between T1DM patients and controls, whereas the same analysis<br />

in AAD subjects revealed slightly higher frequency <strong>of</strong> C(-1123)<br />

allele (p=0.052). C(-1123) allele was significantly more frequent only<br />

in affected AAD males, than in controls (OR 2.79; 95%CI 1.39-5.56;<br />

p=0.003). C1858T polymorphism in PTPN22 gene presented significant<br />

association with T1DM (OR 1.73; 95%CI 1.19-2.51; p=0.004) and<br />

AAD (OR 1.84; 95%CI 1.15-2.94; p=0.010). Association <strong>of</strong> T1858 allele<br />

with T1DM remained significant for both genders, while in AAD<br />

patients it seemed restricted to male population (OR 2.89; 95%CI<br />

1.24-6.76; p=0.011). The haplotype consisting <strong>of</strong> both mutant alleles,<br />

C(-1123)-T1858, was significantly more frequent in T1DM (p=0.003)<br />

and in AAD (p=0.008) than in healthy controls.<br />

Supported in part by Grant N402162533.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!